CardioNerds
Cardionerds is an entertaining and educational medical cardiology podcast created by three cardiologists. They want to bring high yield cardiovascular concepts in a fun and engaging format for their listeners of all levels. Click below to learn more!
Advertisement
The CardioNerds and Dr. Alexander discuss the findings of the ATTRibute-CM clinical trial.
The CardioNerds and Dr. Alexander analyze biomarkers in ATTR-CM.
The CardioNerds and Dr. Kevin M. Alexander discuss the nuances of transthyretin amyloid cardiomyopathy.
Treatment-related early increase in serum transthyretin levels are associated with reduced CV-related hospitalizations.
A study uncovered surprising findings regarding the presence and nature of transthyretin in stenotic aortic valves.
A study investigated the prevalence and implications of ATTR-CA across different heart failure phenotypes.
A case series explored the impact of possessing more than 1 pathogenic variant of the TTR gene on the severity of ATTR.
A study underscores the importance of NT-proBNP as a biomarker in stratifying disease severity in ATTR-CA.
The CardioNerds and colleagues address the topic of familial hypercholesterolemia.
The CardioNerds conference scholars discuss the upcoming Critical Care Cardiology Education Summit.
The CardioNerds and expert faculty Dr. Harriette Van Spall discuss palliative care's role in patients with heart failure.
The CardioNerds and expert faculty Dr. Javed Butler discuss the best next step for a patient with cardiogenic shock.
Intravascular imaging to guide PCI improves hard clinical end points.
A meta-analysis found that peri-device leak on transesophageal echocardiography is both common and dangerous.
Ticagrelor monotherapy after dual-antiplatelet therapy following PCI with DES yields superior outcomes.
Dr. Clark details the MINT trial, which addressed the accurate transfusion threshold in patients with acute MI and anemia.
Dr. Okumus details the ORBITA-2 trial, which marked a significant advancement in understanding and treating stable angina.
CardioNerds correspondent Dr. Ahmed Ghoneem details the positive effects of semaglutide, as demonstrated in the SELECT trial.
CardioNerds correspondent Dr. Christian Inchaustegui details the findings of ARIES-HM3, presented at AHA 2023.
In low-risk patients with symptomatic AS, TAVR is safe, effective, and durable up to 5 years.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.